A method for insertion, maintenance, and removal of urethral catheters in mammals including humans includes steps for preventing or reducing the incidence of catheter associated urinary tract infections. In addition to sterile procedures currently practiced or as may be practiced in the future in connection with catheter use, the method includes the steps of applying an antiseptic, zwitterionic, and acidic skincare solution capable of preserving the stratum corneum to the perineum, meatus, and contiguous mucosa surrounding the insertion site before insertion, after insertion, periodically during the period of indwelling, in connection with any incidence of incontinence, and, optionally, before and after removal of the catheter. Application of the solution optionally is continued after catheter removal on a periodic basis until the threat of an infection associated with catheter use has passed, typically at least about five (5) to seven (7) days and up to thirty (30) days. The solution pH is desirably from about 4.4 to 5.5.

Disclosed herein are improved methods and apparatuses for providing hemostasis within a cavity defined by an internal surface of a bleeding tissue space. A catheter comprising a proximal end and a distal end may be advanced into the cavity through a proximal opening of the tissue space into the cavity. A distal balloon coupled to the catheter may be positioned adjacent a distal opening of the tissue space, and expanded to seal the distal opening. A hemostatic agent may be applied from the catheter to the internal surface of the tissue space to inhibit bleeding of the tissue space. The hemostatic agent may be applied without occluding the proximal opening, the distal opening, and a path extending therebetween with the hemostatic agent.

A method for insertion, maintenance, and removal of urethral catheters in mammals including humans includes steps for preventing or reducing the incidence of catheter associated urinary tract infections. In addition to sterile procedures currently practiced or as may be practiced in the future in connection with catheter use, the method includes the steps of applying an antiseptic, zwitterionic, and acidic skincare solution capable of preserving the stratum corneum to the perineum, meatus, and contiguous mucosa surrounding the insertion site before insertion, after insertion, periodically during the period of indwelling, in connection with any incidence of incontinence, and, optionally, before and after removal of the catheter. Application of the solution optionally is continued after catheter removal on a periodic basis until the threat of an infection associated with catheter use has passed, typically at least about five (5) to seven (7) days and up to thirty (30) days. The solution pH is desirably from about 4.4 to 5.5.

Abstract of the Disclosure Drug delivery devices are provided in which much of a drug payload within the device remains within an area proximal to a wall of the device through which the drug must pass for release of the drug from the device into a patient. In one case, the device may include a drug reservoir portion which has a drug reservoir lumen bounded by a reservoir wall having an inner surface; a drug located in the drug reservoir lumen; and a core region which does not comprise the drug, wherein the drug is disposed between the inner surface of the reservoir wall and the core region. The device may be elastically deformable between a first shape suited for insertion through a lumen into a body cavity of the patient and a second shape suited to retain the device within the body cavity.

An erotic dream induction apparatus includes an inflatable air bladder, such as a rubber balloon, to induce sexual arousal via genital stimulation. The air bladder is brought into contact with either the penis or vagina of the user, and/or is inserted into the anus and/or vagina of the user. In one embodiment, the air bladder is brought into contact with the penis, vagina, and/or anus of the user by being maintained in position near, against, or around the penis, vagina, and/or anus by means of straps or pockets in stimulation underwear, such that when the air bladder is inflated, the air bladder makes contact with at least a portion of the penis, vagina, and/or anus of the user. The air bladder is repeatedly inflated and deflated by pumps and/or valves.

Aspects of the present invention provide a method and a remote-controlled guidance system for delivering and applying medicines to a region of the body that may not otherwise be easily accessible (e.g., to the perianal region). The system is designed to enable the user to administer their medicine at a desirable angle they control, while the user is in a relatively comfortable and efficacious position for the treatment. The device can present a safer, more hygienic, and more effective alternative method to self-administer perianal medicines than any option currently available. To this extent, the system can present a discreet, hands-free alternative to the current options, or couple to other system, such as a bidet toilet seat system, thereby substantially eliminating any discomfort, ineffectiveness, and/or embarrassment a user might otherwise experience.

A catheter including a tube with a coupling assembly at one end. The coupling assembly has an interior volume within which a ball is capture between a seat and a retainer. When fluid flows through the catheter in a first directed the fluid flows around the ball and exits through a port. When fluid starts to back-flow in a second direction the ball seals against the seat preventing flow in the second direction.

The utility model aims at an intimate cleanser, particularly an intimate douche (500) comprising a bag (100), and a fixed and/or threadable applicator nozzle (200), in which the folding bag (100) presents a new practical and anatomic design, resulting in a portable and disposable intimate douche (500). Additionally, the utility model provides irrigation of the pelvic cavity through the flow of content, preferably improved water expelled from the intimate douche (500) into the female and/or male pelvic cavity in order to assist in hygiene, cleansing, treating, odorizing, gut flora replacement, lubrication and/or anesthesia of such cavities.